Logo image
Back
Evidence-based guidelines for the screening, surveillance, and management of VHL manifestations
Book chapter

Evidence-based guidelines for the screening, surveillance, and management of VHL manifestations

Tahsin M. Khan, Shreya Gupta and Naris Nilubol
Von Hippel-Lindau Disease: A Comprehensive Guide to Diagnosis, Treatment, and Management, pp.229-246
Springer
2024
DOI: 10.1007/978-3-031-53858-2_12

View Online

Abstract

Patients with VHL disease develop tumors affecting various organ systems and anatomical locations starting at an early age. Effective management of this disease involves detecting and intervening on these tumors at appropriate timepoints before the development of symptoms or progression to metastatic disease. Screening and surveillance guidelines based on our understanding of the natural history of VHL disease have been developed to guide management of these complex tumors. The goal is to reduce tumor-related morbidity and mortality while preserving organ functions. This chapter summarizes the screening and surveillance guidelines put forth by various international societies as well as the general management strategies for various VHL lesions. In short, patients with VHL should enter screening and surveillance programs—ideally at institutions with multidisciplinary clinics specializing in VHL disease management—at early age and should undergo annual or biennial follow-up to track their disease progression and determine the appropriate time for intervention if needed.
 Surgery Anatomical imaging Functional imaging Genetic testing Management guidelines Management principles Multidisciplinary care Screening and surveillance VHL von Hippel-Lindau (VHL) disease

Details

Metrics

1 Record Views
Logo image